Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

NCT05065411 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Enobosarm & Abemaciclib Combo
DRUG: non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant

Sponsor

Veru Inc.